The preferred file format is Word (.doc). Acceptable formats for pictures,
photographs and figures are .jpg, and .tif. Please do not send pdf files.
Send four hard copies of the manuscript and its electronic version (CD-ROM,
e-mail). The disc must be marked with names of the authors, and the format
and wordprocessor program used. Copies of the manuscript and all enclosures
should be enclosed in hard envelopes to prevent damage during mail handling.
In the electronic version, separate files should be used for the text,
figures, and tables.
Manuscripts should be written on A4 format with double-spacing, providing
25 mm margins. Only one copy of the manuscript should contain the surname
and the first letter of the authors name in the upper right corner. Number
the pages of the manuscript successively,
beginning with the title page as page 1. (http://www.consort-statement.org)
|TITLE PAGE. The title
page should include a concise but informative title, the authors
full names, the department/institution and each authors address
with the symbol to link authors and their addresses. Also,
the title page must include the name, address, fax and telephone
numbers, e-mail of the author to whom correspondence should
be addressed, details of source of support in the form grant,
equipment and drugs, the running title of up to 40 characters,
word counts (for the abstract and the text without the abstract),
the number of figures and tables.
ABSTRACT. The abstract starts on the second page. Original
articles must contain a structured abstract of up to 250 words
or less, titled Background, Material (Patients) and Methods,
Results, and Conclusion. Structured abstracts are not required
in review articles, case reports, and other contributions.
KEY WORDS. Include 3 to 6 key words below the abstract, in
the alphabetical order, taken from the Medical Subject Headings
TEXT should start on the third page.
COVERING LETTER. An example of the covering letter: Those
signed claim that the manuscript has not been published elsewhere
as a whole, or partly. We agree with the content of the manuscript
and approve its publication in the Archive of Oncology. Researching
has been approved by the institutional Ethics Committee. There
are no financial problems that might lead to a conflict of
CONFLICT OF INTEREST. At the end of the text, under a subheading
Conflict of interest statement all authors must disclose
any financial and personal relationship with other people
or organizations that could inappropriately influence their
work. All sources of funding should be declared as an acknowledgement
at the text. For reviewers and authors: please, download the
Declaration of Competing Interest Form from our website:
PREVIOUS PUBLICATION. No substantial part of the manuscript
may have been or may be published elsewhere. This restriction
does not apply to abstracts or press reports published in
connection with scientific meetings. For advice on previous
or simultaneous publication, contact the Editorial Office..
Proofs in PDF format will be sent to the corresponding author via e-mail
and should be returned within 48 hours of receipt. Sending of corrected
proof by fax should be avoided. Corrections should be restricted to typewriting
errors as any substantial changes other than these may be charged to the
author. The responsibility of defetaing errors is with the author.
OFFPRINTS AND REPRINTS
The correspondence authors of all types of articles and meta-analysis,
except letters, news and book reviews, will receive 20 offprints free
of charge. Additional offprints are to be paid and should be ordered when
returning the proof. A photocopy of any article may be obtained at the
price of 5 EUR. All requests for reprints should be addressed to: email@example.com.
Articles should be written according to the unique rules for manuscripts
published in biomedical journals, published by the International Committee
of Medical Journal Editors (Vancouver style) in BMJ 1997;341:1-16 (Serbian
translation taken from the Serbian Archive, special issue 1999;127:88).
Research articles are scientific reports of the results
of original clinical or experimental research. The text
is limited to 3000 words, with structured abstract up to
250 words, maximum of 5 tables and figures (total), and
up to 50 references.
All randomized controlled trials submitted for publication
in the Archive of Oncology should include a completed Consolidated
Standards of Reporting Trials (CONSORT) flow chart. Please
refer to the CONSORT statement website at: http://www.consort-statement.org/statement.html
for more information.Clinical trials should be registrated
in accordance with the criteria outlined by the International
Committee of Medical Journal Editors, including the June
2007 update. (http://www.icmje.org/clin_trial07.pdf).
META-ANALYSES. Meta-analyses are reviews of randomised trials.
Authors are encouraged
to submit QUOROM Statement (Quality of Reporting of Meta-analyses)
which consists of a checklist and flow diagram) or the MOOSE
(Meta-analysis of Observational Studies in Epidemiology).
REVIEW ARTICLES. The editor generally solicits reviews.
These manuscripts summarize the state-of-the-art in a particular
field. They should contain no more than 4000 words, up to
75 references, maximum of 5 tables and figures (total),
and a non-structured abstract of up to 250 words.
CASE REPORTS. These articles should contain no more than
2000 words, excluding the references (up to 25), a non-structured
abstract of up to 250 words, and up to 3 figures. There
should be no more than five authors. A written consent for
publication must be obtained from the patient.
may express opinions on any subject relevant to the journals
aims and scope, or may comment the significance of articles
in the same issue of the journal. The editors usually commission
editorials, but we are happy to consider unsolicited submissions
also. Editorials should contain about 1200 words but its
length may be negotiated at the time of invitation, and
up to 15 references. An abstract is not required.
IMAGING IN CLINICAL ONCOLOGY are classic images of common
medical conditions. Visual images are important part of
much of what we do and learn in medicine. This feature is
intended to capture the sense of visual discovery and variety
that physicians experience. Imaging in clinical oncology
are not intended as a vehicle for case reports.
ONCONET (for information please contact the Editor-in-Chief
or Editor of Onconet.
PERSPECTIVES. are also nearly always solicited, but we are
willing to consider unsolicited
proposals. Perspectives provide background and context for
an article in the issue in which they appear to provide
commentary about an important issue in health care. Perspectives
are limited to 800 words and usually include an illustration,
and no more than five reference citations.
LETTERS TO THE EDITOR. Letters are welcome and will be published
if appropriate. They should be no longer than 500 words
and a maximum of 10 references and 1 figure or table.
SPECIAL COMMUNICATION. These manuscripts describe an important
issue in clinical oncology, or exprimental research in oncology.
Recommended: an unstructured abstract of 200 words, and
no more than 3000 words of the article itself.
COMMENTARY. These manuscripts describe an important topic
in oncology which is not linked to a specific article. Recommended
lenght: up to 2000 words and 1 table or figure, and no more
than 25 references.
NEWS. Report on current research projects of particular
recognition, upon contacts with the editor.
BOOK REVIEWS. Book reviews are solicited by the book review
editor. Unsolicited book reviews are welcome and contain
up to 500 words.
Any substantial error in a published paper will be correceted
as soon as possible.
SUPPLEMENTS / PROCEEDINGS OF SYMPOSIA
Papers from meetings can be published as an extended supplement
to the journal, providing for the full expenses of such
supplements. Supplements are accepted for publication on
the discretion of the Editor-in-Chief if they are to adhere
to editorial policy and acceptance standards, and be subject
to peer review.
|TABLES. Each table
with a brief title should be typed double-spaced on a separate
sheet of paper at the end of your file. Number tables consecutively
(with Arabic numerals) in the order of their first citation
in the text. Give each column a short or abbreviated heading.
Place explanations in legends of all nonstandard abbreviations
used in the table (up to 40 words).
For units and measurements see paragraph below. Do not use
internal horizontal and vertical rules. Always separate the
individual columns using tabulators, not a space bar, i.e.
tables must be in text format.
FIGURES. Line drawings, diagrams and halftone illustrations
etc.) should be designated as figures. They should also be
listed on a separate sheet and numbered consecutively with
Arabic numerals according to the order in which they have
been first cited in the text. Figures should be professionally
drawn (not simply typewritten) and photographed. Each figure
should be labeled on its back indicating the number of the
figure, last name and the first letter of the author, and
the topside of the figure.
Photographs should be supplied in three copies. Color photographs
are published only in case the author himself/herself covers
the expenses. The cost of color reproduction charged to authors
is 50 EUR per color photography. Photomicrographs must have
internal scale markers, and symbols, arrows or letters should
contrast with the background. Photographs of patients must
conceal their identity unless patients written consent for
publishing the photohraph is obtained. If you borrow or use
already published photographs, please submit a written permission
for reproduction. A permission is not required for the documents
in the public domain. For more detailed information you can
Figures will not be returned unless requested. Captions and
detailed explanations of the figures should be given in the
legends. If symbols, arrows, numbers, or letters are used
to identify parts of the figure, identify and explain each
one clearly in the legend. Submit the text and tables of each
manuscript as a single file, but place all figures, charts
etc., in separate files. Allowed graphic formats are EPS,
JPG, and TIF. The figures should be either 8.5 cm or 18.0
cm in size, their minimal resolution 300 dpi. Please send
original photographs, do not send photocopies. Full details
for the electronic submission of artwork
can be obtain from: http://ees.elsevier.com/tsf/img/TSF_Instructions_authors.pdf
ACKNOWLEDGEMENTS. Acknowledgments should precede the reference
list, specifying general support by a department chairman,
acknowledgements of technical help and of financial and material
PERMISSIONS. The author must obtain a permission to reproduce
figures, tables, and the text of the previously published
material, even if that is the author's own work. A written
permission must be obtained from the original copyright holder
(generally the publisher, not the author or editor) of the
journal or book concerned. An appropriate credit should be
included in the reference list. A written permission must
be obtained from the author of any unpublished material cited
from other institutions and should accompany the manuscript.
Sending proofs by fax should be avoided.
FOOTNOTES. Footnotes to the title page and the text are to
be designated consecutively with superscript Arabic numerals.
ADDENDA. Data acquired after acceptance of the paper, by the
authors themselves or by others, cannot be added to the text.
An addendum may be included at the proof stage as a .note
added in proofh, preceding the reference section. However,
such addenda are subject to approval by the Editor-in-Chief
and could result by delay of publication. Addenda should be
kept extremely brief.
UNITS OF MEASUREMENT. Authors should express all measurements
in conventional units, with Systeme International (SI) units
given in parentheses
throughout the text, or authors may consult Units, symbols
and abbreviations: a guide for biological and medical editors
and authors, 5th ed., London: Royal Society of Medicine, 1994,
or Trpinac P, Savin S, Medakovi. B. Internacionalni sistem
mernih jedinica (IS) u medicini i farmaciji, Beograd-Zagreb:
Praxis Medica, Medicinska knjiga, 1979. Also, see http://clincancerres.aacrjournals.org/misc/ifora.shtml.
Figures and tables should use conventional units, with conversion
factors given in legends or footnotes.
ABBREVIATIONS AND SYMBOLS. The Archive of Oncology accepts
Standard Journal of Biological Chemistry Abbreviations. Generally,
avoid abbreviations in the title. In the text, whenever possible,
use standard abbreviations. However, if non-standard abbreviations
are used, the full term of which an abbreviation stands for
should precede its first use in the text. All non-standard
abbrevations should be listed alphabetically on the second
page of a manuscript. Names of symptoms, signs and diseases,
as well as anatomic and histologic characteristics, cannot
be abbreviated. A list of abbreviations and acronyms accepted
for use in the Archive of Oncology can be downloaded from
the following URL: www.aacr.org/pdf_files/Accepted_Abbreviations_Acronyms_2004.pdf
DRUG NAMES. Use generic names for drugs. Commercial names
may be included in parenthesis at first mention in the text.
Authors may consult, for example, the USAN or the USP Dictionary
of Drug Names (1998), and find the relevant data in the National
Drug Registry (NRL 2006), the Agency for Drugs and Medical
Remedies of Serbia, Belgrade 2006, 458 Vojvoda Stepa St.,
11152 Belgrade (www.alims.sr.gov.yu).
Complicated drug names or regimens may be abbreviated, with
the abbreviation in parenthesis after first mention.
GENE NOMENCLATURE. The Archive of Oncology does not italicize
the symbols designating
genes, alleles, or loc. All Human Gene Mapping designations
for human genes should be capitalized.
BIOCHEMICAL NOMENCLATURE. For biochemical nomenclature, authors
may consult www.iubmb.unibe.ch.
MICROARRAY AND PROTEOMIC DATA. The Archive of Oncology requires
that the manuscripts describing microarray data are prepared
to supply peer reviewers with the data in a format that conforms
to the Minimum Information About a Microarray Gene Experiment
(MIAME) guidelines of the Microarray Gene Expression Data
society (MGED) (http://www.mged.org/Workgroups/MIAME/miame.html).
Authors are also encouraged to deposit the data with either
the GEO (http://www.ncbi.nlm.nih.gov/projects/geo)
or Array Express (http://www.ebi.ac.uk)
PROTEOMIC ANALYSES. See Biomolecular Interaction Network Database
SEQUENCE INFORMATION. The author of a manuscript containg
new nucleotide and/or aminoacid sequences are asked to deposit
the sequence information with the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/submit.html),
or to either the European Molecular Biology Laboratory (EMBL)
or the DNA Databank of Japan (http://www.ddbj.nig.ac.jp/sub-e.html).
GUIDELINES FOR STEM CELL RESEARCH. Research with embrionic
stem cells should adhere to the National Academies' Guidelines
for Human Embryonic Stem Cell Research, as published in the
National Academies Press.
TUMORS. Authors are advised to use the TNM staging system
approved by the International Union Against Cancer and the
American Joint Committee on Cancer.
STATISTICAL GUIDELINES. The methods of statistical analysis
describe sufficient details on the analyses carried out to
enable reader to reproduce the analysis if the data were available.
Authors should identify and cite all computer programs or
statistical packages used in the analysis, and measures of
precision and uncertainty for all statistical estimates.
The word .significantg should be used only for statistically
significant results. A p-value or confidence interval (CI)
or other mesures should be citated in the text for any statistically
significant finding reported. Outcome variables should be
given as estimates, with 95% confidence intervals rather than
standard deviations or standard errors.The statistical analysis
may be performed using the regression analysis, adjust/trends,
and explanations for insufficient data. For clinical trials,
it is necessary to report: important study dates, sample size,
interim analyses, compliance to tretments, patient accounting,
and characteristics, follow-up, toxicity, and negative studies.
Bailar JC III, Mosteller F. Guidelines for statistical reporting
in articles for medical journals. Amplifications and explanations.
Ann Interna Med. 1988;108:266-73.
Altman DG. Statistic in medical jornals: some reacent trends.
Statistic Med. 2000;19:3275-89.
Moher D, Schultz KF, Altman DF, CONSORT Group. The CONSORT
statement: revised recommendations for improving the quality
of reports of parallel-group randomized trials. Clin Oral
Cummings P, Rivara FP. Reporting Statistical Information in
Medical Journal Articles Arch Pediatr Adolesc Med. 2003;157:321-4
Hadivuković S. Statistika. 3rd ed. Beograd: Privredni pregled;
REFERENCES. The Archive of Oncology reference style follows
the Uniform Requirements for Manuscripts Submitted to Biomedical
Authors should consult the List of Journals Indexed for MEDLINE
for standard abbreviations of journals (http://www.nlm.nih.gov/tsd/serials/lji.html).
Authors are responsible for accuracy of the literature data.
References should be listed in a separate section immediately
following the text. Only references important for the study
should be cited.
Number references in the order of their first mention in the
text. Cite only the number assigned to the reference, not
Try to avoid using abstracts as references, but if so, after
titles note (abstr.). The abstract cited should not overcome
Examples of correct forms of references:
Begin each reference with authors' list (authors' surname,
initials), which is to be followed by a complete title of
the article, title of the journal (abbreviated), year of publication,
volume number (issue number), and inclusive pages. The first
6 authors are listed; thereafter add et al. after the sixth
Bogdanović G, Kojić V, Đorđević A, Čanadanović-Brunet J, Vojinović-Miloradov
M, Baltić VV. Modulating activity of Fullerol C60(OH)22 on
doxorubicin-induced cytotoxicity. Toxicol in Vitro. 2004;18:629-7.
If the journal has a continuous page numbering, you may omit
the issue number, but if it is not the case, add the month
and date between the year of publication and the volume number.
Books and chapter citations
Citation of a book should contain the author(s), book title,
edition, volume, location and name of the publisher, year
of publication, inclusive pages.
If referencing a chapter of a book, state authors of the chapter,
its title, editor(s) of the book, book title, edition, volume,
location and name of the publisher, year of publication, inclusive
pages of the chapter.
Parmiani G, Lotze MT, editors. Tumor immunology. Molecularly
defined antigens and clinical applications. London-New York:
Taylor & Francis; 2002.
Gray JR, Glatstein E. Radiation therapy in the non-Hodgkinfs
lymphomas. In: Magrath IT, editor. The non-Hodgkin'fs lymphomas.
2nd ed. London-Sidney-Auckland: Arnold; 1997. p. 663-81.
Dissertations and thesis
Bogdanović-Stojanović D. Magnetic resonance mammography in
comparasion to other radiological methods for differentiating
lesions in breast saving surgeries (dissertation). Novi Sad,
Serbia: University of Novi Sad; 2007.
References to information on the Internet
References to information available on the Internet are not
considered legitimate references
because they are not permanent and generally are not peer-reviewed.
If the authors feel that such information would be valuable
to the readers, the URL should be cited in a footnote.
Articles in journals:
Reljin SI, Reljin DB. Fractal geometry and multifractals in
analyzing and processing medical data and images. Archive
of Oncology [Internet]. 2002 [modified 2002 Dec 23; cited
2003 Mar 18]; 10(4):[11 screens]. Available from: http://www.onk.ns.ac.yu/Archive/Vol10/PDFVol10/V10n4p283.pdf
Notice: Only first words of the article title and words that
normally begin with a capital letter are capitalised.
Papers in press
Manuscripts that have been accepted for publication may be
listed among the references with the journal name and tentative
year of publication.
Papers in preparation or submitted for publication, unpublished
data, and personal communications
should be cited in a footnote, not in the reference section.
The names of all authors should be given, along with manuscript
titles if possible. Permission must be obtained from persons
cited in a personal communication.
OBJECT IDENTIFIER. The Archive of Oncology assigns a unique digital
object identifier (DOI) to every article it publishes. The DOI initiative
is an international effort for electronic content identification and is
guided by the International DOI Foundation, composed primarily of academic
publishers and societies. The DOI appears on the title page of the article.
The DOI should be cited in a reference as follows:
Stankov K, Romeo G. Cloning of the genes for non-medullary thyroid cancer:
methods and advances. Arch Oncol. 2006;14(1-2):30-4. DOI: 10.2298/AOO0602030S.
All the material published in the Archive of Oncology represents the
opinions of the authors and does not reflect the opinions of the Oncology
Institute of Vojvodina, the editors, or the institutions with which
the authors are affiliated.
Autors submiting manuscripts to the Archive of Oncology do so with the
that if their manuscript is accepted, the copyright in the article,
including the right to reproduce the article in all forms and media,
shall be assigned exclusively to the publisher (The Oncology Institute
of Vojvodina), and that the corsponding author and all coauthors will
be required to sign and submit a copyright transfer at the time of submition
of the revised manuscript. The Archive Oncology authors retain a number
of nonexlusive rights to their published article.
The copyright transfer agreement can be downloded from www.onk.na.ac.yu/Archive.
All requests to reproduce or make available anything in the journal
as a whole or in its selected part, in electronic or in any other form,
should be sent to:
Archive of Oncology
Oncology Institute of Vojvodina
Institutski put 4, 21204 Sremska Kamenica, Serbia,
Phone: +381 21 480 5550
Fax: +381 21 6613 741
Manuscripts should be submitted to the following address: The Oncology
Institute of Vojvodina, ARCHIVE OF ONCOLOGY, Attn.: Prof. Dr. Vladimir
Vit. Baltić, Editor-in-Chief, Institutski put 4, 21204 Sremska Kamenica,
Serbia, e-mail: firstname.lastname@example.org.